Prime

Type your tag names separated by a space and hit enter

Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies.

Abstract

Several studies conducted worldwide report an inverse association between caffeine/coffee consumption and the risk of developing Parkinson's disease (PD). However, heterogeneity and conflicting results between studies preclude a correct estimation of the strength of this association. We conducted a systematic review and meta-analysis of published epidemiological studies to better estimate the effect of caffeine exposure on the incidence of PD. Data sources searched included Medline, LILACS, Scopus, Web of Science and reference lists, up to September 2009. Cohort, case-control and cross-sectional studies were included. Three independent reviewers selected the studies and extracted the data on to standardized forms. Twenty-six studies were included: 7 cohort, 2 nested case-control, 16 case-control, and 1 cross-sectional study. Quantitative data synthesis of the most precise estimates from each study was accomplished through random effects meta-analysis. Heterogeneity was quantified using the I2 statistic. The summary RR for the association between caffeine intake and PD was 0.75 [[95% Confidence Interval (95%CI): 0.68-0.82], with low to moderate heterogeneity (I2= 28.8%). Publication bias for case-control/cross-sectional studies may exist (Egger's test, p=0.053). When considering only the cohort studies, the RR was 0.80 (95%CI: 0.71-90; I2=8.1%). The negative association was weaker when only women were considered (RR=0.86, 95%CI: 0.73-1.02; I2=12.9%). A linear relation was observed between levels of exposure to caffeine and the RR estimates: RR of 0.76 (95%CI: 0.72-0.80; I2= 35.1%) per 300 mg increase in caffeine intake. This study confirm an inverse association between caffeine intake and the risk of PD, which can hardly by explained by bias or uncontrolled confounding.

Links

Authors+Show Affiliations

,

Center for Evidence-Based Medicine, Faculty of Medicine, University of Lisbon, Portugal.

, , ,

Source

Journal of Alzheimer's disease : JAD 20 Suppl 1: 2010 pg S221-38

MeSH

Caffeine
Central Nervous System Stimulants
Coffee
Cross-Sectional Studies
Databases, Factual
Humans
Meta-Analysis as Topic
Observation
Parkinson Disease
Publication Bias
Risk Factors

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

20182023

Citation

TY - JOUR T1 - Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. AU - Costa,João, AU - Lunet,Nuno, AU - Santos,Catarina, AU - Santos,João, AU - Vaz-Carneiro,António, PY - 2010/2/26/entrez PY - 2010/2/26/pubmed PY - 2010/9/3/medline SP - S221 EP - 38 JF - Journal of Alzheimer's disease : JAD JO - J. Alzheimers Dis. VL - 20 Suppl 1 N2 - Several studies conducted worldwide report an inverse association between caffeine/coffee consumption and the risk of developing Parkinson's disease (PD). However, heterogeneity and conflicting results between studies preclude a correct estimation of the strength of this association. We conducted a systematic review and meta-analysis of published epidemiological studies to better estimate the effect of caffeine exposure on the incidence of PD. Data sources searched included Medline, LILACS, Scopus, Web of Science and reference lists, up to September 2009. Cohort, case-control and cross-sectional studies were included. Three independent reviewers selected the studies and extracted the data on to standardized forms. Twenty-six studies were included: 7 cohort, 2 nested case-control, 16 case-control, and 1 cross-sectional study. Quantitative data synthesis of the most precise estimates from each study was accomplished through random effects meta-analysis. Heterogeneity was quantified using the I2 statistic. The summary RR for the association between caffeine intake and PD was 0.75 [[95% Confidence Interval (95%CI): 0.68-0.82], with low to moderate heterogeneity (I2= 28.8%). Publication bias for case-control/cross-sectional studies may exist (Egger's test, p=0.053). When considering only the cohort studies, the RR was 0.80 (95%CI: 0.71-90; I2=8.1%). The negative association was weaker when only women were considered (RR=0.86, 95%CI: 0.73-1.02; I2=12.9%). A linear relation was observed between levels of exposure to caffeine and the RR estimates: RR of 0.76 (95%CI: 0.72-0.80; I2= 35.1%) per 300 mg increase in caffeine intake. This study confirm an inverse association between caffeine intake and the risk of PD, which can hardly by explained by bias or uncontrolled confounding. SN - 1875-8908 UR - https://www.unboundmedicine.com/medline/citation/20182023/full_citation L2 - https://medlineplus.gov/parkinsonsdisease.html ER -